| Adnan Khazaal Dds Pc | |
|
15031 Michigan Ave Dearborn MI 48126-3443 | |
| (313) 582-3600 | |
| Not Available |
| Full Name | Adnan Khazaal Dds Pc |
|---|---|
| Speciality | Dentist |
| Location | 15031 Michigan Ave, Dearborn, Michigan |
| Authorized Official Name and Position | Adnan A Khazaal (OWNER) |
| Authorized Official Contact | 3135823600 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Adnan Khazaal Dds Pc 15031 Michigan Ave Dearborn MI 48126-3443 Ph: () - | Adnan Khazaal Dds Pc 15031 Michigan Ave Dearborn MI 48126-3443 Ph: (313) 582-3600 |
| NPI Number | 1891248209 |
|---|---|
| Provider Enumeration Date | 08/02/2016 |
| Last Update Date | 08/02/2016 |
| Medicare PECOS PAC ID | 0042590457 |
|---|---|
| Medicare Enrollment ID | O20180115000200 |
News Archive
The Stowers Institute's Baumann Lab has discovered an important step in the maturation pathway of telomerase, the enzyme that replenishes the sequences that are lost at chromosome ends with every cell division.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
BioClinica, Inc., a global provider of clinical trial management solutions, today announced a partnership with Mirada Medical, a leading provider of medical image analysis software. BioClinica will integrate Mirada's XD3 software solution into its imaging core lab technology to further enhance its PET capabilities and expertise for molecular imaging trials.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891248209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | (* (Not Available)) | Primary |
| Provider Name | Adnan Khazaal |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1932115490 PECOS PAC ID: 8022398437 Enrollment ID: I20180115000220 |
News Archive
The Stowers Institute's Baumann Lab has discovered an important step in the maturation pathway of telomerase, the enzyme that replenishes the sequences that are lost at chromosome ends with every cell division.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
BioClinica, Inc., a global provider of clinical trial management solutions, today announced a partnership with Mirada Medical, a leading provider of medical image analysis software. BioClinica will integrate Mirada's XD3 software solution into its imaging core lab technology to further enhance its PET capabilities and expertise for molecular imaging trials.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
› Verified 5 days ago
News Archive
The Stowers Institute's Baumann Lab has discovered an important step in the maturation pathway of telomerase, the enzyme that replenishes the sequences that are lost at chromosome ends with every cell division.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
BioClinica, Inc., a global provider of clinical trial management solutions, today announced a partnership with Mirada Medical, a leading provider of medical image analysis software. BioClinica will integrate Mirada's XD3 software solution into its imaging core lab technology to further enhance its PET capabilities and expertise for molecular imaging trials.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
› Verified 5 days ago
Basha Dental Group Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1756 N Telegraph Rd, Dearborn, MI 48128 Phone: 586-997-9999 | |
Haytham Fares, Dds, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 22190 Garrison St Ste 200, Dearborn, MI 48124 Phone: 313-561-7070 Fax: 313-561-0686 | |
Michigan Healthy Smile Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5728 Schaefer Rd Ste 203, Dearborn, MI 48126 Phone: 313-769-5850 Fax: 313-769-5848 | |
Mercy Dental Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5901 Chase Rd Ste 200, Dearborn, MI 48126 Phone: 313-467-0500 Fax: 313-467-1231 | |
Midwestdental Of Dearborn Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 20055 Carlysle St, Dearborn, MI 48124 Phone: 313-565-1102 | |
Personalized Dental Care Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2532 Monroe St, Dearborn, MI 48124 Phone: 313-563-9090 Fax: 313-563-8237 | |
Raffic A. Mackie D.d.s., P.c.& Associates Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 7911 Wyoming St, Dearborn, MI 48126 Phone: 313-834-9551 Fax: 313-834-9595 |